Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays

Yohei Hisada(University of North Carolina at Chapel Hill), Nigel Mackman(Scripps Research Institute), Nigel S. Key(University of North Carolina at Chapel Hill), Håkan Wallén(Karolinska Institutet), Fariborz Mobarrez(Karolinska Institutet), Raj S. Kasthuri(University of North Carolina at Chapel Hill), Peter M. Voorhees(Levine Cancer Institute), Coleen A. McNamara(University of Virginia), Wyeth Alexander(University of North Carolina at Chapel Hill), Marco Witkowski(Cleveland Clinic), Ursula Rauch(Charité - Universitätsmedizin Berlin), Angela M. Taylor(University of Virginia Health System)
Thrombosis Research
January 18, 2016
10.1016/j.thromres.2016.01.011
Cited by 82

Related Papers

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
|Journal of Clinical Oncology|2019|1.5k
Gut Microbiota and Cardiovascular Disease
|Circulation Research|2020|1k
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
|New England Journal of Medicine|2022|457
Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression
|Blood|2001|368
Elevated Cyclic AMP Inhibits NF-κB-mediated Transcription in Human Monocytic Cells and Endothelial Cells
|Journal of Biological Chemistry|1996|338